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Abstract. The large carboxy-terminal globular domain
(G domain; residues 2,110-3,060) of the A chain of
murine-derived laminin has been shown to promote
heparin binding, cell adhesion, and neurite outgrowth.
This study was conducted to define the potential se-
quence(s) originating from the G domain of laminin
with any of these functional activities. A series of
peptides were synthesized from the G domain, termed
GD peptides, each -20 amino acids long and contain-
ing multiple positively charged amino acids. In direct
3H-heparin binding assays, peptides GD-1 and GD-2
bound high levels of 3H-heparin, while peptides GD-3
and GD-4 bound lower levels of 3H-heparin, and
GD-5 bound essentially no 3H-heparin. The binding of
3H-heparin to peptides GD-1 and GD-2 appeared to be
of high affinity, since significant binding of 3H-heparin
to these two peptides was still observed even when the
NaCl concentration was raised to 1 .0 M . Four of the
T
HE basement membrane glycoprotein laminin isolated
from the murine Engelbreth-Holm-Swarm (EHS) tu-
mor consists ofone 400-kD A chainand two B chains,
each of ti 200 kD. Laminin promotes the adhesion and
spreading of a variety of cells and binds many different types
of molecules, such as glycosaminoglycans or proteoglycans.
Studies using enzymatic digests of laminin or monoclonal
antibodies raised against laminin have defined some of the
biologically active regions ofthe 400-kD A chainof murine
laminin. The large carboxy-terminal globular domain (G do-
main) on the long arm of the A chainof laminin is reported
to be the major heparin binding domain of laminin. In early
studies, enzymatic digests oflaminin were passed over hepa-
rin-affinity columns and proteolytic fragments containing
the G domain were found to adhere (Ott et al ., 1982) . Later
studies using monoclonal antibodies in combination with
heparin-affinity chromatography and a solid-phase radio-
ligand binding assay showed that the G domain, also termed
This work previously appeared in part in abstract form (J. Cell Biol. 1990.
111:143a [Abstr.]; Clin. Exp. Met. 1990. 8 :59 [Abstr.]).
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peptides, GD-1, GD-2, GD-3, and GD-4, directly pro-
moted the adhesion and spreading of HT1080 human
fibrosarcoma cells as well as the outgrowth of neu-
rites from chick spinal cord and dorsal root ganglia
neurons. In addition, solutions of these peptides or
antibodies generated against these peptides inhibited
laminin-mediated HT-1080 cell adhesion. Antibodies
against the 01 integrin subunit inhibited HT-1080 cell
adhesion and neurite outgrowth on surfaces adsorbed
with peptides GD-3 and GD-4 . Therefore, laminin ap-
pears to have multiple, independent sequences in the
G domain that serve a similar cell adhesion promoting
function for different cell types. Furthermore, these re-
sults suggest that the sequences comprising peptides
GD-3 and GD-4 use an integrin as a receptor, of which
the al integrin subunit is a component for these vari-
ous cell types.
the Hep-1 domain, in addition to two domains from other re-
gions of laminin, termed Hep-2 and Hep-3, was important
for heparin binding (Skubitz et al ., 1988). More recently,
electron microscopic examination of laminin-heparin inter-
actions have provided further evidence for the binding of
heparin to the G domain of laminin (Kouzi-Koliakos et al .,
1989).
Other biological activities attributed to the A chain of
laminin include promotion of neurite outgrowth from neu-
rons and cell adhesion, which is localized to part of the G
domain and the region directly above the G domain, termed
fragment E8 (Edgar et al., 1984, 1988; Engvall et al ., 1986;
Goodman et al ., 1987; Deutzmann et al., 1990). In addition,
the amino-terminal globular domain on the "short" arm at the
top of the molecule is involved in laminin-laminin self-
assembly (Yurchenco et al., 1985 ; Schittny and Yurchenco,
1990) and the adhesion of hepatocytes (Timpl et al., 1983).
Over the past few years, the amino acid sequences of the
Bl, B2, and A chains of laminin have been determined
(Barlow et al., 1984; Sasaki et al ., 1987, 1988; Sasaki and
Yamada, 1987; Pikkarainen et al ., 1987, 1988 ; Hard et al.,1988); this has permitted the synthesis of various peptides
from domains of laminin that could then be screened for
specific functional activities present within the intact mole-
cule. Four peptides from the BI chain of laminin have been
reported to promote cell adhesion: YIGSR, located near the
intersection of the cross (Graf et al., 1987a,b; C16ment et
al., 1990); peptide F-9 (RYVVLPRPVCFEKGMNYTVR)
located on the inner globule ofthe lateral short arm (Charonis
et al., 1988) which contains the active T mer RYVVLPR
(Skubitz et al., 1990) ; peptide AC15 (RIQNLLKITNLRIK-
FVK) derived from the outer globule ofthe lateral short arm
(Kouzi-Koliakos et al., 1989) ; and peptide PDSGR near the
cross region (Kleinman et al., 1989) . Only one synthetic
peptide has been reported from the 132 chain of laminin to
have functional activity (Liesi et al., 1989). This peptide,
P20 (RNIAEIIKDI), stimulates neurite outgrowth of both
central and peripheral neurons (Liesi et al., 1989) .
Sincethe A chain was the most recent chain oflaminin for
which the entire amino acid sequence was predicted, only a
few functional activities have been ascribed to synthetic pep-
tides. Synthetic peptide PA 21 (residues 1,115-1,129; CQAG-
TFALRGDNPQG), which contains the active sequence RGD,
promotes cell attachment (C18ment et al., 1990; Tashiro et
al., 1991) and induces the attachmentof human endothelial
cells through an integrin receptor (Grant et al ., 1989). Pep-
tide PA22-2 (residues 2,091-2,108; SRARKQAASIKVAVS-
ADR), which has been reported to contain the active se-
quence IKVAV (Tashiro et al., 1989) promotes hepatocyte
attachment (Cl6ment et al., 1990), neuronal process exten-
sion (Tashiro et al., 1989; Sephel et al., 1989), and increases
experimental metastasis of the lungs by increasing collagen-
ase IV activity when murine melanoma cells are preincubated
with the peptide (Kanemoto et al ., 1990).
To our knowledge, however, there have been no studies
that have reported on the biological activity of synthetic pep-
tides or expressed fragments from the G domain of laminin,
which is the major heparin binding site on laminin that also
promotes cell adhesion. In this study, we have synthesized
peptides, each of ti20 amino acid residues in length, from
the published amino acid sequence of the G domain of the
A chain of murine EHS tumor-derived laminin (Sasaki et
al., 1988) . Sequences from this domain were selected for
synthesis based on their relatively low hydropathy indexes
(indicative ofhydrophilic regions) and relativelyhigh density
of positively charged amino acid residues (arginines and ly-
sines). In addition, the peptides, termed GD-1 through GD-5,
were selected from regions at the ends of the five loops of
the A chain with the thought thatthese domains wouldpoten-
tially be more accessible for the binding of cells, proteo-
glycans, and/or glycosaminoglycans such as heparin-like
molecules. The synthetic peptides were screened for their
ability to bind 3H-heparin and/or promote the adhesion and/
or spreading ofHT-1080 humanfibrosarcoma cells. The pep-
tides and antibodies raised against the peptides were also as-
sayed for their ability to inhibit laminin-mediated HT-1080
cell adhesion. Furthermore, these peptides were tested for
their ability to promote the outgrowth of neurites from chick
spinal cord (SC)' neurons as well as dorsal root ganglia
(DRG) neurons. Antibodies against the ,0l integrin subunit
1. Abbreviations used in thispaper: DRG, dorsal root ganglia; OVA, oval-
bumin; RLBA, radioligand binding assay; SC, spinal cord.
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were then used to inhibit the adhesion of HT1080 cells and
the outgrowth ofneurites from DRG neurons on surfaces ad-
sorbed with the peptides.
Materials and Methods
ProteinsandSynthetic Peptides
Laminin was isolated from the EHS tumor as described previously (Palm
and Furcht, 1983) and fibronectin was isolated from human plasma as de-
scribed previously (McCarthy et al., 1986). Thepurity ofboth proteinswas
verified by SDS-PAGE and ELISA. BSA (grade V, fatty acid free) and oval-
bumin (OVA) were purchased from Sigma Chemical Co., St. Louis, MO.
The five peptides listed in Table I, GD-1 to GD-5, were derived from the
G domain (residues2,110-3,060) ofthe AchainofEHS laminin. Theamino
acid residues of the four "active" peptides, GD-1 to GD-4, were randomly
scrambled (Table 1) in order to ensure that the primary amino acid se-
quences were essential for the functional activity ofthese peptides and that
biological activity was not merely due to the peptides' net charge or amino
acid composition. Peptides were synthesized by Dr. Bianca Conti-Tronconi
(University ofMinnesota, St. Paul, Minnesota) or the Microchemical Fa-
cility at the University ofMinnesota, then purified as previously described
(Charonis et al., 1988). Purity was checked by HPLC and amino acid
analysis.
Quantitation ofPeptides Adsorbing toSurfaces
Each ofthe peptides was synthesized with a tyrosine residue at the carboxy
terminus and purified by HPLC. The peptides were then radiolabeled with
'251 as previously described (Chelberg et al., 1990). The amount of each
peptide adsorbed to the wells was quantitated as previously described
(Skubitzet al., 1990). Briefly, 50gl ofradiolabeled peptides diluted in PBS
to concentrations ranging from 2 to 200 hg/ml were added to 96-well poly-
styrene Immulon 1 microtiter plates (Dynatech Laboratories, Inc., Chan-
tilly, VA) and incubatedovernight at 29°C. The next day, wells were treated
for 2 h with 2 mg/ml BSA in DME containing 20 mM Hepes, pH 7.4, then
washed three times with this buffer. The radioactivity was removed and
quantitated in a gamma counter.
SolidphaseRadioimmunoassays
The binding of 3H-heparin to synthetic peptides and OVA was quantitated
by a solid-phase radioligand binding assay (RLBA) in microtiter plates as
previously described (Skubitz et al., 1988) with minor modifications.
Briefly, 50 pl of the peptides at various concentrations in PBS containing
0.02% NaN3 were added to each well and adsorbed overnightat 29°C. The
next day, 200 wl of RLBA buffer (2 mg/ml OVA in 0.02 M Tris, pH 6.8,
0.15 M NaCI) was added to each well followed by a 90-min incubation at
37°C. After removal ofthis buffer, 50 iel of 3H-heparin (100,000 dpm; 0.3
mCi/mg; Du Pont-New England Nuclear Research Products, Boston, MA)
in RLBA buffer was added to each well and the plates were incubated at
37°C for 2 h. Unbound 3H-heparin was removed by washing three times
with wash buffer (RLBAbuffer containing 0.1% CHAPS). Tritiatedheparin
was solubilized by incubation with 200 Wl of 0.05 N NaOH and 1% SDS
for 30 min at 60°C and quantitated in a scintillation counter (model LS-
3801; Beckman Instruments, Inc., Palo Alto, CA). All experiments were
repeatedaminimum ofthree times and done inquadruplicate. Other experi-
ments were similarly conducted in which various concentrations of NaCl
(0.05-2.0 M) were present in the RLBA buffer.
Antibodies
Synthetic peptides were coupledtothe carrier protein keyholelimpethemo-
cyanin (KLH) as previously described (Skubitz et al., 1990) . Briefly, pep-
tides wereconjugated to KLH by use of 1-ethyl-3(3-dimethylaminopropyl)-
carbodiimidehydrochloride (Sigma Chemical Co.), then dialyzedinto PBS,
and stored at 70°C for later use. Polyclonal antibodies were generated
against the synthetic peptides or the synthetic peptides coupled to KLH as
previously described (Skubitz et al., 1990). Briefly, rabbits were immunized
with peptides or peptides/KLH, sera was tested for specificity by ELISA,
then IgG was purified by ammonium sulfate precipitation and DEAF column
chromatography. Purity of IgG was assessed by SDS-PAGE and ELISA.
Monoclonal antibody P4C10 was generated in mice against the human
#1 integrin subunit as described (Carter et al., 1990). Monoclonal antibody
1138Table I. Laminin A Chain Peptides Synthesized
* Based on Sasaki et al., 1988. (G, glycine; A, alanine; V, valine; L, leucine; I, isoleucine; F, phenylalanine; Y, tyrosine; W, tryptophan; M, methionine; C, cys-
teine; S, serine; T, threonine; H, histidine; K, lysine; R, arginine; D, aspartate; E, glutamate; N, asparagine; Q, glutamine; P, praline.)
* Calculated by assuming a + 1 net charge for lysine (K) and arginine (R) residues and a - 1 net charge for glutamic acid (E) and aspartic acid (D) at neutral
pH. Histidine is assumed to be uncharged at this pH.
4 Calculated by the method of Kyte and Doolittle (1982). According to this method, more hydrophobic peptides correspond to the more positive numerical values.
W1B10, generated in mice against the chicken Sl integrin subunit, was
provided as purified IgG as agenerous gift from Dr. Rick Horwitz (Univer-
sity of Illinois, Champaign-Urbana, IL) .
Cells
The HT1080human fibrosarcoma cell line was purchased from the Ameri-
can Type Culture Collection (Rockville, MD) and was maintained in MEM
with nonessential amino acids (Gibco Laboratories, Grand Island, NY)
containing 10% FBS. PC12 rat pheochromocytoma cells were kindly
provided by Dr. Lloyd Greene (New York University, NY) and were main-
tained in DME containing 10% FBS and 5% horse sera. Cells were pas-
sagedfor 4-5 wk and then replaced from frozen stocks ofearly passagecells
to minimize phenotypic drift. All cells were maintained at 37*C in a hu-
midified incubator containing 5% C02.
DRG from embryonicday 12 (1112) or SC from E8 White Leghornchicks
were dissected, and the cells dissociated by a 20-min incubation in 0.25 %
trypsin followed bygentle trituration. Cells were washed twice to inactivate
the trypsin in F14 medium (Gibco Laboratories) buffered with bicarbonate,
containing 10% calf sera, 5 pg/ml insulin, 5 mM phosphocreatine, 5 ng/ml
sodium selenite, 0.1 mg/ml transferrin, 0.4 mg/ml sodium pyruvate, and 20
nM progesterone (all purchased from Sigma Chemical Co.), and 15 ng/ml
/3-NGF, a generous gift of Dr. Bernard Mirkin, University of Minnesota.
The neuronal cells were then resuspended in serum-free media for use in
neurite outgrowth assays described below.
CellAdhesion Assays
The direct adhesion of HT-1080 or PC12 cells to surfaces adsorbed with
peptides or proteins was performed as described previously (Skubitz et al .,
1987; Charonis et al ., 1988). Briefly, HT-1080 cellswereradiolabeled over-
night in MEM containing 10% FBS plus 3 jXi/ml of [3H]thymidine (6.7
Ci/mmol, New England Nuclear), whereas PC12 cells were radiolabeled
overnight in DME containing 10% FBS, 5% horse sera, and 71 ACi/ml of
Tran "S-label (70% [35S]-L-methionine; 1,024 Ci/mmol; ICN Biomedi-
cals, Inc., Irvine, CA). The next day, radiolabeled HT-1080 cells were re-
moved from the flasks by gentle trypsinization, while HBSS was used to re-
move the PC12 cells from the flasks as previously described (Charonis et
al., 1988). Radiolabeled cells were then added to 96-well microtiter plates
adsorbed with various concentrations of synthetic peptides, laminin, OVA,
or poly-L-lysine. After a 2-h incubation, loosely or nonadherent cells were
removed by washing the wells three times. Adherent cells were solubilized
andquantitated in a scintillation counter. Experiments were donein quadru-
plicate and repeated three times.
Quantitation ofHT-1080 Cell Spreading
Spreading ofthe adherent HT-1080 cells was evaluated by performing adhe-
sion assays similar to those described above, except instead of solubilizing
the adherent cells, they were fixed with 2% glutaraldehyde in PBS at 23*C
for 1 h. The glutaraldehyde was then removed and the cells were stained
with Coomassie brilliant blue R (Sigma Chemical Co.) as previously de-
scribed (Skubitz et al., 1990). Cell spreading was quantitated by measuring
the average surface area occupied by a cell using an Opto-Max Image Ana-
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InhibitionofLaminin-mediated HT-1080
CellAdhesion
Inhibitionof HT-1080 cell adhesion to surfaces coated with laminin by solu-
ble synthetic peptides or specific antibodies was performed as previously
described (Skubitz et al., 1990). Briefly, radiolabeled cells at 5 x 10°/ml
were incubated for 30 min with various concentrations of synthetic peptides
in DME/Hepes containing 2 mg/ml BSA. 100 pl ofthe cell suspension was
then addedtowells precoated with 1.5,ugoflamininor 1.0pg offibronectin.
The cells were incubated in the wells for 20 min at 37°C, then the wells
were washed, and adherent cells were quantitated. Cell viability after a 1-h
incubation in the presence ofthe peptide "inhibitors" was assessedby trypan
blue dye exclusion. Inall cases, the cellswere >95 % viable, and no toxicity
ofthe peptides was observed at the indicated concentrations tested. All ex-
periments were repeated at least three times in quadruplicate.
In similar assays, 100 /Al of DME/Hepes containing 2 mg/ml BSA and
100 pg/ml of purified IgG from normal rabbits or from rabbits immunized
with the synthetic peptides was added to wells that were precoated in qua-
druplicate with 0.3 Ag of laminin or fibronectin. The IgG was incubated for
1 h at 37°C in the wells, then radiolabeled HT-1080 cells were added to the
wells and incubated for 30 min at 37°C. Wells were then washed and cells
were quantitated.
Neurite Outgrowth Promoted by Peptides
lyzer. In addition, thenumber ofcells that spread oneach surfacewas deter-
mined by visually monitoring adherent cells in each well and determining
the percent of those cells that had spread. 150 cells were visualized for
spreading on each of the different surfaces. Each experiment was done in
quadruplicate and repeated three times.
Chick neurons were resuspended in serum-free media at 40,000 cells/ml
(DRG) or 60,000 cells/ml (SC). 100 plwereadded to each well ofa microti-
ter plate precoated with various concentrations of the synthetic peptides,
laminin, or OVA as described above for the cell adhesion assays. Neuronal
cells were allowed to extend neurites for 24 h at 37°C, in 5 % C02. Adher-
ent cells were fixed with 2% glutaraldehyde for 20-40 min, washed, and
counted using phase-contrast microscopy with a 1Ox objective on a Nikon
inverted microscope. Cells were counted in 1 diameter across each well,
3.5 field of views (ti20% of the total area of each well). Neurons were
identified according to morphology as having round, phase-bright cell bod-
ies, and scored as having neurites if there was at least one process longer
than the cell diameter. All experiments were repeated at least two times in
triplicate. Photographs ofneurite outgrowth were taken ona Nikon Diaphot
microscope using Kodak Pan-X film.
Inhibition ofPeptide-mediated Cell Adhesion by
an Antibody against the 011ntegrin Subunit
Inhibition of HT-1080 cell adhesion to surfaces adsorbed with laminin or
the peptides by an antibody against the Sl integrin subunit was performed
essentially as described above for the inhibition assays using the peptides
as inhibitors of cell adhesion. Briefly, radiolabeled human HT-1080 cells
Peptide Sequence*
Sequence
numbers*
Net
charge#
Hydropathy
index4
GD-1 KATPMLKMRTSFHGCIK 2,615-2,631 +5 -5.1
GD-2 KEGYKVRLDLNITLEFRTTSK 2,890-2,910 +2 -10.1
GD-3 KNLEISRSTFDLLRNSYGVRK 2,443-2,463 +3 -8 .6
GD-4 DGKWHTVKTEYII{RKAF 2,779-2,795 +4 -17 .8
GD-5 TSLRKALLHAPTGSYSDGQ 2,547-2,565 +2 -11 .8
GD-1"S" LGHMITFKKPSKTMRAC Scrambled +5
GD-2"S" LGIKTKSRKDLEFTLVNTREY Scrambled +2
GD-3"S" SRLKNVDLGRTFRSENSLIKY Scrambled +3
GD-4"S" VKTHRWFKGAEDIKTKY Scrambled +4E
Ó
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Figure 1. Binding of 3H-heparin to "native" or "scrambled" pep-
tides. 3H-heparin (100,000 dpm in 20 mM Tris, pH 6.8, containing
2 mg/ml OVA and 0.15 M NaCl)was added to wells adsorbed with
3 Ag of native peptides (solid bars) or scrambled peptides (hatched
bars)and incubated for 2 h at 37°C. Each value represents the mean
of four separate determinations t SD. Duplicate experiments gave
similar results.
were incubated for 20 min at 37°C in DME/Hepes containing 2 mg/ml BSA
and various dilutions of supernatant from monoclonal antibody P4C10
against the human 01 integrin subunit or control supernatant. Cells were
then added to wells preadsorbed with 0.7 hg of laminin or the peptides. All
experiments were repeated at least four times in quadruplicate.
Inhibition ofPeptide-mediated Neurite Outgrowth by
an Antibody against the 01 Integrin Subunit
Microtiter wells were adsorbed with 1 Wg of the peptides or laminin. Chick
DRG neurons were cultured for 24 h in media containing 10 pg/ml of
purified normal mouse IgG or mouse monoclonal antibody WlB10 IgG,
which recognizes the chicken 01 integrin subunit. Neurons were then
added, in the continuedpresence ofthe IgG, to the microliter wells and cul-
tured for 24 h. Neurite outgrowth was quantitated by counting fixed cells,
as described above. All experiments were done in triplicate and repeated
at least two times.
Efficiency ofPeptide Adsorption to Surfaces
To ensure that the peptides would adsorb to the polystyrene
microtiter wells, peptides were radiolabeled with 'III and
the amount of each peptide bound to the wells was quanti-
tated. Equivalent levels of adsorption were observed for all
five of the peptides when they were added in the range of
0.1-10 Ecg per well (data not shown).
3H-Heparin Binding to Laminin A Chain Peptides
The binding of 3H-heparin to laminin A chain peptides was
measured in a direct solid phase binding assay whereby vari-
ous amounts of the peptides were adsorbed to plates and
3H-heparin was added to each well. Peptides GD-1 and
GD-2 bound the most 3H-heparin (Fig. 1) in a concentra-
tion dependent manner (data not shown) with a maximum of
-30,000 dpm of the input 3H-heparin binding to peptide
GD-2 at a coating concentration of 3 ug/well. Significantly
lower levels of 3H-heparin bound to peptides GD-3 and
GD-4; maximal levels of only -5,000 dpm of 3H-heparin
bound (Fig. 1). Less than -500 dpm of the input 3H-
heparin bound to peptide GD-5 even at the highest coating
concentration of 5 l~g peptide/well (data not shown). In-
terestingly, no correlation was observed between the ability
of the peptide to bind 3H-heparin and its net charge or
hydropathy index. For example, peptides GD-2 and GD-3
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both have a positive net charge (+2 and +3, respectively)
and similar negative hydropathy indexes (-10.1 and -8.6,
respectively; indicating relative hydrophilicity), however at
a coating concentration of 3 ug/well, peptide GD-2 bound
-30,000 dpm of the input 3H-heparin while peptide GD-3
bound less than -5,000 dpm. As expected, based on the
multiple heparin-binding domains on the intact laminin mol-
ecule, the binding of 3H-heparin to peptides GD-1 and GD-2
was less than the binding of 3H-heparin to laminin on a mo-
lar basis, i .e., 1/40th the amount of 3H-heparin bound to
these peptides compared to laminin on a molar basis. Also,
as expected, solutions of these peptides were not able to in-
hibit 3H-heparin binding to laminin (data not shown). This
is most likely attributed to the multiplicity of heparin-bind-
ing siteson laminin (Skubitz et al., 1988), such that one pep-
tide cannot compete for the multiple heparin-binding sites on
laminin.
As further evidence that the primary sequence of amino
acid residues comprising each synthetic peptide was critical
for its 3H-heparin binding activity, we randomly "scram-
bled" the amino acid residues and synthesized a series of
"scrambled" peptides, GD-1 "S" through GD-4 "S" (Table I) .
In all cases, the "native" peptides bound 3H-heparin at lev-
els significantly higher than the respective "scrambled" pep-
tides (Fig. 1).
Effect ofSalt Concentration on 3H-Heparin Binding
to Peptides
To determine the relative affinity of the peptides for heparin,
we performed 3H-heparin binding assays in which increas-
ing concentrations of NaCl were present in the incubation
buffer. 3H-heparin binding to peptides GD-1 to GD-4 de-
creased as the salt concentration increased. Significant bind-
ing of 3H-heparin to peptides GD-1 and GD-2 above back-
ground levels was still observed in 1.0 M NaCl, suggesting
that the affinity of binding is quite high relative to peptides
GD-3, GD-4, and GD-5 (data not shown) .
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Figure 2. Adhesion of HT1080 human fibrosarcoma cells to lami-
nin A chain peptides. Microtiter wellswere adsorbed with increas-
ing concentrations of lantinin (o), or peptides GD-1 (o), GD-2
(m), GD-3 (o), GD-4 (o), GD-5 (0), or OVA (A), and radiolabeled
HT-1080 human fibrosarcoma cells were allowed to adhere for 2 h
as described in Materials and Methods. Each value represents the
mean offour separate determinations f SD. Three separate experi-
ments gave similar results.TableII. Quantitation ofHT-1080 Human
Fibrosarcoma Cell Spreading on Surfaces Adsorbed
with Laminin A Chain Peptides
* 50 pl of each peptide or protein at 50 jig/ml was adsorbed to the wells of
microtiter plates, cells were incubated for 2 h, then cell spreading was quanti-
tated as described in Materials and Methods.
$ Cell spreading is quantitated as a percentage of the number of adherent cells
that spread.
Cell Adhesion to Peptides
We were next interested in determining whether there was
a relationship between the ability ofpeptides to bind heparin
and their ability to promote cell adhesion . In this study, ra-
diolabeled HT-1080 fibrosarcoma cellswere incubated in mi-
crotiter plates adsorbed with increasing concentrations of
laminin or the peptides (Fig. 2) . The cellsadhered to laminin
and peptides GD-1, GD-2, GD-3, and GD-4 in a concentra-
tion-dependent manner. Coating concentrations as low as 0.5
p,g/well of each ofthese four peptides promoted cell adhesion
above background levels (celladhesion on surfaces adsorbed
with OVA). Maximal adhesion of the added cells (ti100%)
occurred at coating concentrations of 3 hg/well of peptide
GD-1. Interestingly, the two peptides that bound the most
3H-heparin, GD-1 and GD-2, promoted the highest levels
of cell adhesion . Peptides GD-3 and GD-4 were also capable
of promoting cell adhesion (albeit at a lower level, Fig. 2);
these peptides had shown limited ability to bind 3H-heparin
(Fig. 1) . Peptide GD-5, however, promoted neither cell adhe-
sion nor bound 3H-heparin. Using various coating concen-
trations, the following was observed: 2 hg of laminin (i .e.,
2 .3 pmol) promoted the adhesion of HT-1080 cells to a level
comparable to 0.3 wg of peptides GD-1 or GD-2 (i .e., 150
pmol) or 5 /Ag of peptides GD-3 or GD-4 (i .e., 2,500 pmol) .
These results suggest that peptides GD-1 and GD-2 are an
order of magnitude more active than peptides GD-3 and
GD-4 at promoting the adhesion of HT-1080 cells under
these experimental conditions. One possible explanation as
to why fewer cells adhered to laminin compared to peptides
GD-1 and GD-2 is that less laminin is present in the microti-
ter wells on a molar basis compared to the amount of pep-
tides present in the wells. Therefore, since comparatively
less laminin is present in the wells, fewer functionally active
sites are available to which the cells can adhere.
Cell Spreading on Laminin Synthetic Peptides
Most of the HT-1080 fibrosarcoma cells that were incubated
for 2 h on polystyrene plates adsorbed with laminin spread
out and became elongated. The spreading of these cells was
quantitated by measuring the mean surface area occupied by
the cells. 98% of the cells that adhered to surfaces adsorbed
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with laminin spread out to cover an average surface area of
610 jAmz (Table II) . On surfaces adsorbed with the synthetic
peptides GD-1 and GD-2, -85 % ofthe adherent cells spread,
whileon surfaces adsorbed with the synthetic peptides GD-3
and GD-4 only -15 % of the adherent cells spread. The ap-
pearance of the cells that adhered to surfaces adsorbed with
the peptides was different than those cells present on surfaces
adsorbed with laminin since they were more flattened and
had numerous extended processes, frequently resulting in a
stellate appearance (not shown). Quantitatively, those cells
that spread on the synthetic peptides occupied an average
area of ti 380 pmz (Table II); -60% of the spreading caused
by intact laminin. The few fibrosarcoma cells that remained
on the surfaces coated with BSA, poly-L-lysine, or peptide
GD-5 were spherical and did not flatten or spread after 2 h;
these cells only occupied an average area of -60-120 p.mz
(Table II) .
Inhibition ofLaminin-mediated Cell Adhesion
by Synthetic Peptides
To determine if the specific amino acid sequences compris-
ing the biologically active synthetic peptides were function-
ally active in the intact laminin molecule, radiolabeled HT
1080 cells were preincubated with various concentrations of
the synthetic peptides or OVA, then added to wells coated
with laminin or fibronectin. The four peptides that directly
promoted cell adhesion, peptides GD-1, GD-2, GD-3, and
GD-4, were also found to inhibit laminin-mediated cell
adhesion in a concentration-dependent manner when pep-
tides were added in solution (Fig. 3) . Peptide GD-1 was the
most effective peptide at inhibiting cell adhesion to laminin;
100 ug/ml caused -75 % inhibition ofcell adhesion (Fig. 3).
Peptides GD-2 and GD-3 inhibited laminin-mediated cell
adhesion to almost the same extent; this inhibition was inde-
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Figure 3 Inhibition of laminin-mediated cell adhesion by peptides.
Radiolabeled HT1080 human fibrosarcoma cells were preincubated
for 30 min in various concentrations of peptides GD-1 (o), GD-2
(m), GD-3 (o), GD-4 (0), or GD-5 (0), then added to wells ad-
sorbed with 1.5 tug of laminin. After a 30-min incubation, the non-
adherent cells were aspirated off and the wells were washed three
times. Adherent cells were quantitated in a scintillation counter.
Cell inhibition is expressed as a percent relative to the number of
cells binding to laminin-coated surfaces in the absence of inhibi-
tors. Each value represents the mean of four separate determina-
tions f SEM. Three separate experiments gave similar results.
Peptide or protein*
Surface area occupied
by a cell
Cells
spread$
pmz
Peptide GD-1 396 t 32 83
Peptide GD-2 388 f 29 85
Peptide GD-3 360 t 27 12
Peptide GD-4 372 f 33 15
Peptide GD-5 59 f 4 0
Laminin 610 f 62 98
BSA 63 t 4 0
Poly L-lysine 119 f 32 5Table III. Reactivity ofPurified IgG Raised againstLaminin A Chain Peptides
* Wells were coated with 0.05 ug of peptide GD-1, 0.125 Ag of peptide GD-2, 1 jig of peptides GD-3, GD-4, and GD-5, and 3 Ag of laminin, fibronectin, or
ovalbumin. ND, not done.
t Purified IgGfrom normal rabbits or rabbits immunized with the synthetic laminin Achain peptides wasadded to the wells at 100 ;+g/ml .The ELISA wasper-
formed as described in Materials and Methods, and absorbance readings at 490 run were taken. Thevalues shown are the mean of quadruplicate wells ±SDwith
background readings using normal rabbit IgG subtracted. Where the background reading exceeded the absorbance using IgG from the rabbits immunized with
the peptides, zero has been used.
pendent of theirheparin binding activity since peptide GD-2
binds high levels of 3H-heparin, whereas peptide GD-3
binds low levels of 3H-heparin. Peptide GD-4 inhibited cell
adhesion to the least extent; 100 ug/ml inhibited cell adhe-
sion to laminin only -20% . Peptide GD-5, which neither
promoted heparin binding nor cell adhesion, did not inhibit
Lmnin-mediated cell adhesion. None of the peptides in-
hibited cell adhesion on surfaces adsorbed with fibronectin,
suggesting the binding specificity of the laminin peptides.
In the next series of experiments, a checkerboard-type
analysis was conducted whereby HT-1080 cells were incubat-
ed with 30 pg/ml of each ofthe peptides, GD-1 through GD-5,
in the presence of 30 ,ug/ml of a second peptide in order to
determine if an additive or synergistic effect of inhibition of
Lmnin-mediated cell adhesion could be obtained. When
two exogenous peptides were added concomitantly, an addi-
tive effect of inhibition was observed for peptides GD-1
through GD-4 (data not shown) .
As further evidence that the precise sequence of amino
acid residues comprising each synthetic peptide was critical
for its cell adhesion activity, inhibition assays were per-
formed in order to determine if peptides GD-1"S" through
GD-4"S, in which the amino acid sequences were "scram-
bled" (Table I), could inhibit Lmnin-mediated HT-1080 cell
adhesion. When tested at the same concentrations that
caused inhibition with the "native" unscrambled peptides, the
"scrambled" peptides did not cause significant inhibition
(data not shown) .
Inhibition ofLaminin-mediated CellAdhesion
by Anti-peptideAntibodies
Polyclonal antibodies were raised in rabbits against the syn-
thetic peptides or peptide/KLH and the specificity of the
purified IgG was verified by ELISA. Each of the purified
IgGs reacted specifically with theirrespective peptide (Table
III). The IgG raised against peptides GD-1 and GD-3 were
also very reactive with the intact laminin molecule, while the
IgG raised against peptides GD-2 and GD-4 reacted sig-
nificantly, albeit less well, with intact laminin. It is possible
that the regions of laminin comprising peptides GD-2 and
GD-4 are "hidden" within the globular domain, and are not
as readily accessible as the sequence epitopes of peptides
GD-1 and GD-3. The IgG generated against the synthetic
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peptides reacted at background levels, ifat all, with fibronec-
tin, OVA, or the other synthetic peptides ('fable III) .
As further proofthat the amino acid sequences comprising
peptides GD-1 through GD-4 were functionally active in the
intact Lmnin molecule, the purified anti-peptide IgGs were
tested for their ability to inhibit Lmnin-mediated HT1080
cell adhesion. In all cases, the anti-peptide IgGs were able
to causepartial inhibition (-30-50%) on surfaces adsorbed
with laminin (Fig. 4). Since laminin is a very large molecule
with many sites that promote cell adhesion, it was expected
that antibodies raised against only one of these sites could
not totally inhibit cell adhesion. The anti-peptide IgGs also
caused complete inhibition of cell adhesion on surfaces ad-
sorbed with their respective peptide, but had no effect on sur-
faces adsorbed with the other unrelated cell adhesion pro-
moting laminin GD peptides or fibronectin (data not shown).
Figure 4. Inhibition of Lmnin-mediated HT1080 cell adhesion
with antibodies against the peptides. Microtiter wells went; ad-
sorbed with 0.3 gg of laminin, then 100 ug/ml ofpurified IgG from
normal rabbits or rabbits immunized with the synthetic peptides
GD-1/KLH, GD-2/KLH, GD-3, or GD-4/KLH were incubated in
the wells for 1 h. Radiolabeled HT-1080 cells were then added to
the wells and the number of cells adhering was quantitated as de-
scribed in Materials and Methods. Cell adhesion is expressed as the
number ofcellsthat adhered to laminin in the presence of the IgG
as a percent ofthe cells that adhered in the absence ofthe IgG. Each
value represents the mean of four separate determinations t SD.
Three separate experiments gave similar results.
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N. rabbit Anti-GD-1 Anti-GD-2 Anti-GD-3 Anti-GD-4
Purified IgG (100 ug/ml)
Adsorbed
antigen* GD-1/KLH
Purified IgG*
GD-2/KLH GD-3 GD-4/KLH
Peptide GD-1 1 .06 t 0.06 0 0 0.11 t 0.06
Peptide GD-2 0 0.33 t 0.02 0 0
Peptide GD-3 0 ND 1 .14 t 0.07 0
Peptide GD-4 0 0 0.18 t 0.08 0.91 t 0.11
Peptide GD-5 0 0 0 0.02 t 0.02
Laminin 0.70 t 0.04 0.01 t 0.00 0.64 t 0.01 0.10 t 0.01
Fibronectin 0 0 0.06 t 0.01 0
Ovalbumin 0 0 0 0.01 t 0.01Figure 5 . Morphology of chick SC neurons or DRG neurons on laminin peptides . Chick SC neurons (a-d) or DRG neurons (e-h) were
incubated for 24 h in microtiter wells preadsorbed with 1 hg of laminin or the synthetic peptides, then photographed as described in
Materials and Methods . SC neurons extended neurites on surfaces adsorbed with laminin (a), peptide GD-1 (b), and peptide GD-3 (c),
but noton peptideGD-5 (d) . DRGneurons extended neurites on surfaces adsorbed with laminin (e), and peptide GD-2 (f), peptide GD-3
(g), but not on peptide GD-5 (h). Bar, 30 j,m .
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Figure 6. Laminin A chain peptides promote the outgrowth of
neurites from SC neurons. Microtiter wells were adsorbed with
increasing concentrations of laminin (e) or peptides GD-1 (o),
GD-2 (a), GD-3 (o), GD-4 (o), GD-5 (0), or OVA (A), and
chick SC neurons were then added. At the end of a 24-h incubation,
the number of SC neurons that had extended neurites was quanti-
tatedas described in Materials and Methods. Each value represents
the mean of three separate determinations and the SE was < 10% .
Three separate experiments gave similar results.
PC12 Cell Adhesion to Peptides
The G domain of laminin is known for its ability to promote
neurite outgrowth in vitro. To ensure that the cell adhesion
promoted by these laminin A chain peptides was not re-
stricted to human fibrosarcoma cells, a neural crest derived
cell line, PC12 rat pheochromocytoma cells, was examined.
The PC12 cellsadhered to the laminin peptides in a concen-
tration-dependent manner similar to the HT-1080 cells (data
not shown). As with the HT1080 cells, peptides GD-1 and
GD-2 promoted the highest level of cell adhesion, whereas
peptides GD-3 and GD-4 promoted lower, albeit significant,
levels of PC12 cell adhesion. Neither peptide GD-5 nor OVA
promoted PC12 cell adhesion .
Neurite Outgrowth on Surfaces Adsorbed with
Laminin or .Peptides
Since neural crest derived cells were able to adhere to the
laminin A chain peptides, we next tested to see if the peptides
could promote neurite outgrowth of primary neuronal cells.
Microtiter wells adsorbed with laminin or the peptides
promoted the outgrowth of neurites from both SC and DRG
neurons after a 24-h incubation. On surfaces adsorbed with
laminin, SC neurons tended to extend only one long neurite
per neuron and thus appeared unipolar (Fig. 5 a). In con-
trast, the majority of SC neurons appeared multipolar on
surfaces adsorbed with peptides GD-1, GD-2, GD-3, or
GD-4; representative examples are shown of neurons on
peptides GD-1 (Fig. 5 b) and GD-3 (Fig. 5 c) where several
small neuritic extensions per neuron were observed . The few
SC neurons that adhered to surfaces adsorbed with peptide
GD-5 (Fig. 5 d) or OVA (not shown), did not extend neurites.
In contrast, the morphology ofDRG neurons incubated on
surfaces adsorbed with laminin (Fig. 5 e), or peptides GD-2
(Fig. 5f), GD-3 (Fig. 5 g), GD-1 (not shown), or GD-4 (not
shown) appeared very similar. Over 95% of the DRG neu-
rons that extended neurites on these surfaces had extended
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multiple neurites per neuron. No neurite outgrowth was ob-
served from DRG neurons incubated on surfaces adsorbed
with peptide GD-5 (Fig. 5 h) or OVA (not shown) .
Neurite outgrowth was quantitated by counting the num-
ber of neurons on equivalent areas of each surface that had
extended neurites. Lammin and peptides GD-1 through GD-4
promoted the outgrowth ofneurites from SC neurons (Fig. 6)
and DRG neurons (not shown) in a concentration-dependent
manner. Peptides GD-1 and GD-2 promoted a greater number
ofSC neurons to extend neurites than did laminin or peptides
GD-3 and GD-4. In contrast, laminin was a more potentpro-
moter of neurite outgrowth from DRG neurons compared to
any of the peptides (see below). SC and DRG neurons ex-
tended very few neurites on surfaces adsorbed with either
peptide GD-5 or OVA.
Inhibition ofPeptide-mediated CellAdhesion by
an Antibody against the /31 Integrin Subunit
Since integrins have been implicated as receptors that medi-
ate the adhesion of a variety of cells to laminin, we wanted
to determine if any of the laminin peptides that promote hu-
man HT1080 fibrosarcoma cell adhesion do so by interact-
ing with the (31 integrin subunit. To address this question, we
performed HT-1080 cell adhesion assays on surfaces ad-
sorbed with the lamininpeptides in the presence of monoclo-
nal antibody P4C10 generated against the human fl integrin
subunit. 60% fewer cells adhered to surfaces adsorbed with
laminin or laminin peptides GD-3 and GD-4 when a 1:50 di-
lution ofmonoclonal antibody P4C10 was present, compared
to when the antibody was absent (Fig. 7). However, mono-
clonal antibody P4C10, at the same 1:50 dilution, had no
effect on cell adhesion to peptides GD-1 or GD-2 (Fig. 7).
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Figure 7. Inhibition of HT1080 cell adhesion to laminin and lami-
nin peptides by a monoclonal antibody against the 01 integrin
subunit. Radiolabeled human HT-1080 fibrosarcoma cells were
preincubated with various dilutions ofmonoclonal antibody P4C10
against the human al integrin subunit. Cells were then incubated
for 30 min in wellspreadsorbed with laminin (9) or peptides GD-1
(o), GD-2 (m), GD-3 (o), and GD-4 (o). The number of cells ad-
hering was quantitated as described in Materials and Methods. Cell
adhesion is expressed as the number of cells that adhered to the sub-
strate in the presence of the anti-(31 integrin subunit antibody as
a percent of the cells that adhered in the absence of the antibody.
Each value represents the mean of four separate determinations
t SD. Triplicate experiments gave similar results.
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Figure 8. Inhibition of neurite outgrowth on laminin peptides by a
monoclonal antibody against the 01 integrin subunit. Chick DRG
neurons were preincubated with normal mouse IgG (solid bars) or
purified IgG from the mouse monoclonal antibody W1B10 that
recognizes the chicken /31 integrin subunit (hatched bars), then
added to wells adsorbed with 1 wg of laminin or the synthetic lami-
nin A chain peptides. After a 24-h incubation, the number of neu-
rons that had extended neurites was quantitated as described in
Materials and Methods. Each value represents the mean of three
separate determinations f SE. Duplicate experiments gave similar
results.
InhibitionofPeptide-mediatedNeurite Outgrowth by
anAntibodyagainst theail Integrin Subunit
Since expression of the X31 integrin subunit has been demon-
strated on developing neurons (Bozyczko and Horwitz,
1986; Tomaselli et al ., 1988a; Letourneau and Stattuck,
1989), we performed neurite outgrowth assays on surfaces
adsorbed with laminin peptides using monoclonal antibody
WIB10 against the chicken (31 integrin subunit as an inhibi-
tor. Chick DRG neurons extended significantly fewer neu-
rites on surfaces adsorbed with laminin, peptide GD-3, or
peptide GD-4 in the presence of the anti-integrin monoclo-
nal antibody, compared to when normal mouse IgG was
present (Fig. 8). These results suggest that the sequences in
laminin comprisingpeptides GD-3 and GD-4 use an integrin
as a receptor, of which the 01 integrin subunit is a compo-
nent. In contrast, the monoclonal antibody had no effect on
DRG neurite outgrowth on surfaces adsorbed with peptides
GD-1 or GD-2 under identical conditions.
Based upon earlier observations indicating that the G domain
of laminin binds heparin, and hence, perhaps interacts with
cellular glycosaminoglycans or proteoglycans, we synthe-
sized 20' mer peptides from the G domain of laminin in an
attempt to further define biologically active sequences from
this region. Previously, this domain was shown to be the ma-
jor of a number of heparin binding domains of laminin and
was termed Hep-1 (Skubitz et al., 1988). The peptides syn-
thesized were of relatively similar positive net charge and
negative hydropathy. Interestingly, in direct solid-phase
binding assays, two of the peptides, GD-1 and GD-2 (net
charges of +5 and +2, respectively), bound heparin at very
high levels while peptides GD-3 and GD-4 (net charges of
Skubitz et al . Cell- and Heparin-binding Laminin A Chain Peptides
+3 and +4, respectively) bound significantly less heparin,
and peptide GD-5 (net change +2) did not bind heparin.
This was somewhat of a surprise as one might have predicted
that the more highly cationic peptides would bind heparin
more effectively simply on a basis of net charge. It caused
some consternation that we were unable to predict from the
net charge or hydropathy index whether or not a peptide
would bind heparin. The finding that two peptides from the
G domain of laminin both promote high levels of heparin
binding is not unexpected due to previous reports that de-
scribed this domain as the major heparin binding site of
laminin (Ott et al., 1982; Skubitz et al., 1988). In fact, since
the G domain is predicted by computer analysis to consist
of five loops (Sasaki et al., 1988), it is quite possible that
regions on each of these loops may act in concert to bind
heparin. Furthermore, six additional -20' mer peptides
from the G domain of laminin also bind 3H-heparin (Wilke
and Skubitz, 1991; Skubitz, A. P. N., unpublished observa-
tion) and may help to account for the G domain being the
major heparin binding domain of laminin.
Previous studies had shown by rotary shadowing and elec-
tron microscopy that heparin bound to laminin at the G do-
main in 0.2 M NaCl, while binding of heparin to other do-
mains of laminin only occurred at lower salt concentrations
(Kouzi-Koliakos et al., 1989) . We were therefore interested
to study the strength of the interaction between 3H-heparin
and the peptides by determining whether binding or dissocia-
tion of laminin A chain peptides to heparin was sensitive to
increasing salt concentrations. In the present study, signifi-
cant binding of3H-heparin to peptides GD-1 and GD-2 was
observed even at salt concentrations as high as 1.0 M NaCl.
These results indicate that there are at least two regions on
the G domain of laminin that bind heparin at relatively high
salt concentrations (i.e. approximately six to seven times
physiological salt concentrations) ; this provides a potential
explanation for why the G domain of laminin is the "major"
heparin binding site on laminin and can be called Hep-1
in context with the other sites on laminin that appear to
show lesser affinity (Skubitz et al., 1988; Kouzi-Koliakos et
al., 1989).
Proteoglycans with heparin-like side chains are present on
cell surfaces and in basement membranes (Lindahl and
H66k, 1978; Gallagher et al., 1986; Stow and Farquhar,
1987; Ruoslahti, 1988 ; Klein et al., 1988) . The interaction
of proteoglycans with laminin by way of specific peptide se-
quences may serve to regulate cell adhesion and spreading.
For this reason, we tested the peptides for their ability to
directly promote the adhesion of HT1080 human fibrosar-
coma cells, since intact laminin significantly promotes the
adhesion of HT-1080 cells. These studies showed that four
of the five peptides from the G domain of laminin promoted
cell adhesion . Interestingly, peptides GD-1 and GD-2, which
bound heparin, promoted higher levels of cell adhesion than
peptides GD-3 and GD-4, which bound less heparin. The
finding that four different sequences from the G domain of
laminin promote cell adhesion is not again surprising since
other large extracellular matrix proteins such as fibronectin
and type IV collagen are known to contain a variety of do-
mains and specific peptide sequences involved in similar
functions (Chelberg et al ., 1990 ; McCarthy et al., 1990) .
Our results also suggest that the four peptide sequences
that directly promote cell adhesion play an important role in
1145the intact laminin molecule, since they each inhibited cell
adhesion to surfaces adsorbed with laminin . The ability of
any one peptide to significantly inhibit cell adhesion to an
intact molecule that contains multiple cell adhesion promot-
ing sequences suggests that there may be some common
pathway or rate limiting step subsequent to cell recognition
ofadhesive peptide sequences . As further evidence thatthese
four peptides play an important role in HT1080 cell adhe-
sion, we have shown that antibodies generated against these
peptides react with laminin by ELISA and inhibit laminin-
mediated HT-1080 cell adhesion .
In addition, the four peptides that promoted cell adhesion
also promoted HT-1080 cell spreading . The area occupied by
cells on surfaces adsorbed with any of these active peptides
was -60% of the spreading observed on intact laminin .
These results indicate that the process of cell spreading is
quite complex and may require multiple peptide sequences,
perhaps from the other chains oflaminin, for cells to acquire
the characteristic phenotypic appearance of cells adherent
and spreading on laminin .
Since theG domain oflaminin has been shown to promote
the outgrowth of neurites from neurons, we next conducted
assays to determine if the GD peptides could affect the be-
havior of a variety of neural crest and neuronally derived
cells . Peptides GD-1 through GD-4 promoted the adhesion
of PC12 cells, as well as the outgrowth ofneurites from both
chickSC andDRG neurons . Interestingly, neurite outgrowth
from DRG neurons on surfaces adsorbed with laminin ap-
peared morphologically identical to DRG neurons on sur-
faces adsorbed with the peptides ; whereas neurites extended
in a unipolar manner from SC neurons on surfaces adsorbed
with laminin and in a multipolar manner from SC neurons
on surfaces adsorbed with thepeptides . These results suggest
that neurite outgrowth from these two different neuronal cell
types may be mediated by laminin through different mecha-
nisms . Importantly, both primary neurons and neuronally
derived tumor cells are able to interact with these laminin
peptides .
Theamino acid residues comprising these fivemouseEHS
laminin A chain peptides were compared with the residues
ofhuman laminin and found to be quite similar. The murine
peptides had -70-100% identity and 93-100% similarity to
the corresponding human sequences as determined using the
Dayhoff matrix . When these five mouse lamininA chain pep-
tide sequences were compared to amino acid sequences of
other proteins by computer searches of the Protein Identifi-
cation Resource of the National Biomedical Research Foun-
dation, Washington,D.C ., Protein Database (04/23/91), sev-
eral stretches of 5 or 6 amino acid residues of identity were
found . Of most potential relevance was the finding that hu-
man merosin contains the sequenceG F K V_G L_D L_L V
E F _E F _R _T _T (Ehrig et al ., 1990), that has X60 %identity
(underlined residues) and 88% similarity to a 17 amino acid
overlap in peptide GD-2 . TheM subunit ofmerosin, a mole-
cule present in muscle fiber basal laminae, but absent from
many other basal laminae (Lievo and Engvall, 1988), has
been shown to be a homologue of the A chain of laminin
(Ehrig et al ., 1990) that also promotes the adhesion ofsome
neurons (Sanes et al., 1990) .
Another important feature of laminin is its ability to as-
sociate with cell surface receptors and consequently modify
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cellular phenotypes in various ways. Receptors for laminin
have been isolated from a variety of normal and malignant
cell lines (see reviews by von der Mark and Kuhl, 1985 ;
Martin and Timpl, 1987; Reichardt and Tomaselli, 1991) . In
many cases, the laminin receptor has been determined to be
an integrin (Horwitz et al ., 1985 ; Bozyczko and Horwitz,
1986 ; Helmer et al ., 1988 ; Tomaselli et al ., 1987, 1988a,b,
1990 ; Sorokin et al., 1990, and references therein) . These
findings suggest that different cell types adhere to specific
domains of laminin based on their various cell surface re-
ceptors .
Due to the importance of integrin receptors in mediating
cell adhesion to laminin, we tested the ability of monoclonal
antibodies raised against the ,131 integrin subunit to inhibit
peptide-mediated HT-1080 cell adhesion and neurite out-
growth . On surfaces adsorbed with peptides GD-3 and GD-4,
monoclonal antibodies against the /31 integrin subunit par-
tially inhibited both HT-1080 cell adhesion and the outgrowth
of neurites from chick DRG neurons . These results suggest
that the sequences oflaminin comprising peptides GD-3 and
GD-4 (which do not bind 3H-heparin) permit the interac-
tionoflaminin with cells by way oftheir 01 integrin subunits ;
whereas the sequences of laminin comprising peptides GD-1
and GD-2 (which bind 3H-heparin) may be interacting with
cells by way of their cell surface glycosaminoglycans/pro-
teoglycans, though other explanations may exist .
Recently, an a3 (31 integrin isolated from osteosarcoma
cells has been reported to bind to the carboxy terminus of
the BI chain of laminin (Gehlsen et al., 1989) . Other groups
have used monoclonal antibodies against specific integrin a
or a subunits in combination with proteolytic fragments of
laminin to localize regions of laminin to which integrin
subunits bind . In their studies, the integrin al subunit has
been shown to bind to the core and proximal portions of the
short arms of the cross region of laminin, whereas the inte-
grina6 subunit and0 01 binds to the long arm of laminin
containing theG domain (Tomaselli et al ., 1990 ; Hall et al .,
1990 ; Sonnenberg et al ., 1988, 1990) . Recently, a monoclo-
nal antibody to VLA-6 has been reported to inhibit HT-1080
cell adhesion to laminin A chain peptide PA21, which con-
tains the RGD sequence from the region above the intersec-
tion ofthe cross (Tashiro et al ., 1991) . To date, however, the
exact amino acid sequence ofthe regions of laminin to which
the various integrin or other receptors binds is unknown . Fu-
ture studies will attempt to isolate the cell surface receptors
for the biologically active A chain peptides described in this
study. Of particular interest is /31,4 galactosyltransferase
which has just recently been shown to serve as a cell surface
receptor for the G domain oflaminin (Begovac et al ., 1991) .
Based on the ability of these peptides to promote heparin
binding and cell adhesion, the peptides fell into three catego-
ries : group I peptides (includes GD-1 andGD-2) bound high
levels of heparin and were effective at promoting cell adhe-
sion; group II peptides (includes GD-3 and GD-4) bound
less heparin, but were quite active at promoting cell adhe-
sion ; and group III peptides (includes GD-5) bound neither
heparin nor cells . These data indicate that multiple se-
quences of laminin present inthe G domain may act to pro-
mote cell adhesion and/or heparin binding ; potentially in-
creasing the level of interaction due to their close proximity .
These findings suggest the existence of at least two potential
1146classes of cell receptors which interact with the G domain
of laminin : heparin-like (i.e ., glycosaminoglycan/proteogly-
cans) and integrins .
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